Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma

1. Chari, A.
2. Martinez-Lopez, J.
3. Mateos, M.-V.
4. Bladé, J.
5. Benboubker, L.
6. Oriol, A.
7. Arnulf, B.
8. Rodriguez-Otero, P.
9. Pineiro, L.
10. Jakubowiak, A.
11. de Boer, C.
12. Wang, J.
13. Clemens, P.L.
14. Ukropec, J.
15. Schecter, J.
16. Lonial, S.
17. Moreau, P.